Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CMAB Bolsters Executive Team | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

CMAB Bolsters Executive Team

Names Ye Shi as head of quality

By: Contract Pharma

Contract Pharma Staff

CMAB Biopharma (Suzhou) Inc., a biologics contract manufacturing and development organization (CDMO), has appointed Ye Shi as the head of quality. He will be responsible for the overall management of the quality system within CMAB.
 
Yongzhong Wang, chief executive officer, CMAB, said, “We are very pleased to welcome Mr. Ye Shi to CMAB. In the Chinese biopharmaceutical and CDMO industries, quality experts like Mr. Ye Shi are very rare. He has both front-line practical experience as well as success in managing an entire company quality system both at home and abroad. We believe that his leadership will greatly strengthen CMAB’s world-class CDMO quality system and provide our customers with more outstanding services.
 
Over the last 30 years, Mr. Ye Shi has worked in biopharmaceutical companies in both China and the U.S. and promoted their quality management towards a world-class level. Before joining CMAB, he served as the deputy general manager and quality assurance director at QILU Pharmaceutical Co., Ltd. There, he successfully led the team to pass the pre-inspection approval (PAI) of antibody drugs by the Chinese Centre for Drug Evaluation (CDE), which subsequently successfully entered commercialization.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters